Cite

HARVARD Citation

    Chu, J. et al. (2019). Cost‐effectiveness of immune checkpoint inhibitors for microsatellite instability–high/mismatch repair–deficient metastatic colorectal cancer. Cancer. 125 (2), pp. 278-289. [Online]. 
  
Back to record